266 related articles for article (PubMed ID: 22226054)
1. Hyperinsulinemia enhances c-Myc-mediated mammary tumor development and advances metastatic progression to the lung in a mouse model of type 2 diabetes.
Ferguson RD; Novosyadlyy R; Fierz Y; Alikhani N; Sun H; Yakar S; Leroith D
Breast Cancer Res; 2012 Jan; 14(1):R8. PubMed ID: 22226054
[TBL] [Abstract][Full Text] [Related]
2. Insulin-sensitizing therapy attenuates type 2 diabetes-mediated mammary tumor progression.
Fierz Y; Novosyadlyy R; Vijayakumar A; Yakar S; LeRoith D
Diabetes; 2010 Mar; 59(3):686-93. PubMed ID: 19959755
[TBL] [Abstract][Full Text] [Related]
3. Insulin-mediated acceleration of breast cancer development and progression in a nonobese model of type 2 diabetes.
Novosyadlyy R; Lann DE; Vijayakumar A; Rowzee A; Lazzarino DA; Fierz Y; Carboni JM; Gottardis MM; Pennisi PA; Molinolo AA; Kurshan N; Mejia W; Santopietro S; Yakar S; Wood TL; LeRoith D
Cancer Res; 2010 Jan; 70(2):741-51. PubMed ID: 20068149
[TBL] [Abstract][Full Text] [Related]
4. Hyperinsulinemia promotes metastasis to the lung in a mouse model of Her2-mediated breast cancer.
Ferguson RD; Gallagher EJ; Cohen D; Tobin-Hess A; Alikhani N; Novosyadlyy R; Haddad N; Yakar S; LeRoith D
Endocr Relat Cancer; 2013 Jun; 20(3):391-401. PubMed ID: 23572162
[TBL] [Abstract][Full Text] [Related]
5. EMT reversal in human cancer cells after IR knockdown in hyperinsulinemic mice.
Zelenko Z; Gallagher EJ; Antoniou IM; Sachdev D; Nayak A; Yee D; LeRoith D
Endocr Relat Cancer; 2016 Sep; 23(9):747-58. PubMed ID: 27435064
[TBL] [Abstract][Full Text] [Related]
6. Inhibiting PI3K reduces mammary tumor growth and induces hyperglycemia in a mouse model of insulin resistance and hyperinsulinemia.
Gallagher EJ; Fierz Y; Vijayakumar A; Haddad N; Yakar S; LeRoith D
Oncogene; 2012 Jul; 31(27):3213-22. PubMed ID: 22037215
[TBL] [Abstract][Full Text] [Related]
7. Silencing vimentin expression decreases pulmonary metastases in a pre-diabetic mouse model of mammary tumor progression.
Zelenko Z; Gallagher EJ; Tobin-Hess A; Belardi V; Rostoker R; Blank J; Dina Y; LeRoith D
Oncogene; 2017 Mar; 36(10):1394-1403. PubMed ID: 27568979
[TBL] [Abstract][Full Text] [Related]
8. Investigating new therapeutic strategies targeting hyperinsulinemia's mitogenic effects in a female mouse breast cancer model.
Rostoker R; Bitton-Worms K; Caspi A; Shen-Orr Z; LeRoith D
Endocrinology; 2013 May; 154(5):1701-10. PubMed ID: 23515289
[TBL] [Abstract][Full Text] [Related]
9. Insulin receptor phosphorylation by endogenous insulin or the insulin analog AspB10 promotes mammary tumor growth independent of the IGF-I receptor.
Gallagher EJ; Alikhani N; Tobin-Hess A; Blank J; Buffin NJ; Zelenko Z; Tennagels N; Werner U; LeRoith D
Diabetes; 2013 Oct; 62(10):3553-60. PubMed ID: 23835331
[TBL] [Abstract][Full Text] [Related]
10. Identification of VEGF-regulated genes associated with increased lung metastatic potential: functional involvement of tenascin-C in tumor growth and lung metastasis.
Calvo A; Catena R; Noble MS; Carbott D; Gil-Bazo I; Gonzalez-Moreno O; Huh JI; Sharp R; Qiu TH; Anver MR; Merlino G; Dickson RB; Johnson MD; Green JE
Oncogene; 2008 Sep; 27(40):5373-84. PubMed ID: 18504437
[TBL] [Abstract][Full Text] [Related]
11. Ovariectomy is associated with metabolic impairments and enhanced mammary tumor growth in MKR mice.
Ben-Shmuel S; Scheinman EJ; Rashed R; Orr ZS; Gallagher EJ; LeRoith D; Rostoker R
J Endocrinol; 2015 Dec; 227(3):143-151. PubMed ID: 26383532
[TBL] [Abstract][Full Text] [Related]
12. Highly specific role of the insulin receptor in breast cancer progression.
Rostoker R; Abelson S; Bitton-Worms K; Genkin I; Ben-Shmuel S; Dakwar M; Orr ZS; Caspi A; Tzukerman M; LeRoith D
Endocr Relat Cancer; 2015 Apr; 22(2):145-57. PubMed ID: 25694511
[TBL] [Abstract][Full Text] [Related]
13. Attenuated transforming growth factor beta signaling promotes metastasis in a model of HER2 mammary carcinogenesis.
Novitskiy SV; Forrester E; Pickup MW; Gorska AE; Chytil A; Aakre M; Polosukhina D; Owens P; Yusupova DR; Zhao Z; Ye F; Shyr Y; Moses HL
Breast Cancer Res; 2014 Oct; 16(5):425. PubMed ID: 25280532
[TBL] [Abstract][Full Text] [Related]
14. Caloric restriction coupled with radiation decreases metastatic burden in triple negative breast cancer.
Simone BA; Dan T; Palagani A; Jin L; Han SY; Wright C; Savage JE; Gitman R; Lim MK; Palazzo J; Mehta MP; Simone NL
Cell Cycle; 2016 Sep; 15(17):2265-74. PubMed ID: 27027731
[TBL] [Abstract][Full Text] [Related]
15. Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion.
Williams TM; Medina F; Badano I; Hazan RB; Hutchinson J; Muller WJ; Chopra NG; Scherer PE; Pestell RG; Lisanti MP
J Biol Chem; 2004 Dec; 279(49):51630-46. PubMed ID: 15355971
[TBL] [Abstract][Full Text] [Related]
16. Metastasis is an early event in mouse mammary carcinomas and is associated with cells bearing stem cell markers.
Weng D; Penzner JH; Song B; Koido S; Calderwood SK; Gong J
Breast Cancer Res; 2012 Jan; 14(1):R18. PubMed ID: 22277639
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the WAP-Myc mouse mammary tumor model for spontaneous metastasis.
Utz B; Turpin R; Lampe J; Pouwels J; Klefström J
Sci Rep; 2020 Oct; 10(1):18733. PubMed ID: 33127915
[TBL] [Abstract][Full Text] [Related]
18. Collagen induced arthritis increases secondary metastasis in MMTV-PyV MT mouse model of mammary cancer.
Roy LD; Ghosh S; Pathangey LB; Tinder TL; Gruber HE; Mukherjee P
BMC Cancer; 2011 Aug; 11():365. PubMed ID: 21859454
[TBL] [Abstract][Full Text] [Related]
19. An novel inhibitor of TGF-β type I receptor, IN-1130, blocks breast cancer lung metastasis through inhibition of epithelial-mesenchymal transition.
Park CY; Min KN; Son JY; Park SY; Nam JS; Kim DK; Sheen YY
Cancer Lett; 2014 Aug; 351(1):72-80. PubMed ID: 24887560
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of mammary gland involution is associated with transforming growth factor alpha but not c-myc-induced tumorigenesis in transgenic mice.
Sandgren EP; Schroeder JA; Qui TH; Palmiter RD; Brinster RL; Lee DC
Cancer Res; 1995 Sep; 55(17):3915-27. PubMed ID: 7641211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
